MPG.eBooks - Description: Current utilization of antipsychotic agents for schizophrenia

Cover Image

Read Now

Current utilization of antipsychotic agents for schizophrenia combination and high-dose therapies

The objective of this report is to identify current utilization and expenditure on combinations and high doses of atypical antipsychotic agents for adolescents and adults with schizophrenia, in public and private drug plans in Canada

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health August 2012, 2012
Series:	CADTH optimal use report
Subjects:	Schizophrenia / Drug Therapy Canada Health Expenditures Antipsychotic Agents / Administration & Dosage Insurance, Pharmaceutical Services Dose-response Relationship, Drug Drug Therapy, Combination
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK361501
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this report is to identify current utilization and expenditure on combinations and high doses of atypical antipsychotic agents for adolescents and adults with schizophrenia, in public and private drug plans in Canada
Item Description:	"This report was prepared by the Canadian Agency for Drugs and Technologies in Health (CADTH)"--T.p. verso
Physical Description:	1 PDF file (ii, 30 pages) illustrations